Table 1.
Characteristics of study population.
| N | Mean | SD | |
|---|---|---|---|
| Enrolled in study | 42 | ||
| Withdrew before starting treatment | 1 | ||
| Eligible for analysis | 41 | ||
| Age (years) | 41 | 59 | 9.97 |
| GOG performance status | |||
| 0 | 11 | 26.83 | |
| 1 | 30 | 73.17 | |
| Measurable disease | |||
| Yes | 9 | 21.95 | |
| No | 32 | 78.05 | |
| Race | |||
| White | 35 | 85.37 | |
| Black | 1 | 2.44 | |
| Hispanic | 2 | 4.88 | |
| Other | 2 | 4.88 | |
| Missing | 1 | 2.44 | |
| Disease status | |||
| Primary | 39 | 95.12 | |
| Recurrence | 2 | 4.88 | |
| Stage | |||
| 1C | 1 | 2.44 | |
| IIA | 1 | 2.44 | |
| IIIA | 10 | 24.39 | |
| IIIC | 21 | 51.22 | |
| 1VA | 1 | 2.44 | |
| IVB | 7 | 17.07 | |
| Grade | |||
| 1 | 7 | 17.07 | |
| 2 | 17 | 41.46 | |
| 3 | 17 | 41.46 | |
| Histology | |||
| Endometrioid | 32 | 78.05 | |
| Serous | 4 | 9.76 | |
| Mucinous | 1 | 2.44 | |
| Adenosquamous | 3 | 7.32 | |
| Endometrioid + Serous | 1 | 2.44 | |
| Lymph node dissection | |||
| Yes | 36 | 87.8 | |
| No | 3 | 4.88 |